Budgeting and Contracting Best Practices for Research Sites
To grow your business, negotiate and collect fair payment for your work by understanding its true costs before budget discussions.
To grow your business, negotiate and collect fair payment for your work by understanding its true costs before budget discussions.
Every site is different. Learn how to meet their unique needs and make workflows and collaboration more efficient in this blog.
Sponsor and contract research organization (CRO) team members such as clinical research associates (CRAs), study managers, and startup specialists collaborate
Sites and sponsors can adopt strategies to reduce quality issues and avoid FDA warning letters by improving collaboration, training, and resource access.
The clinical trial startup process has seen significant shifts over the past five years: growth in decentralized trials, improved technology,
DMCs play a vital role in clinical trials by independently reviewing interim data for safety and effectiveness, ensuring participant protection throughout the study.
Oncology trials face unique hurdles in innovation, enrollment, and endpoints, requiring strategic planning to address complex study demands and precision needs.
This blog explores how research sites are focusing on their institutional biosafety committee (IBC) programs as part of overall study activation time.
With MCA processes slowing trial activation, AACI suggests sponsors play an active role in MCA preparation to reduce budget and startup delays.
The study startup process is a critical point in research, and oftentimes, can make or break a study’s success.
The Food and Drug Administration’s (FDA’s) proposed single institutional review board (sIRB) mandates are in part designed to support greater
Effective negotiation balances firm priorities with flexibility, helping sites align sponsor budgets with true costs while avoiding compliance pitfalls.